Main Session
Sep 28
QP 14 - Modernizing Definitive Therapy in Cervical Cancer: From Systemic Intensification to Adaptive Radiation

1082 - Contrast-Free Virtual Enhancement: Multi-Modal Deep Learning Synthesis of CECT from pCT and MRI

05:25pm - 05:30pm ET
Room 204

Presenter(s)

Haonan Xiao, PhD - Shandong First Medical University Affiliated Tumor Hospital, Jinan City, Shandong

J. Chen1, H. Xiao2, and Y. Yin3; 1Cancer Hospital of Shandong First Medical University, Shandong, China, 2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China, 3Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Purpose/Objective(s):

Contrast-enhanced CT (CECT) is routinely used in radiotherapy planning to improve visualization of tumors, lymph nodes, and vascular anatomy for accurate target delineation. However, contrast administration is contraindicated in a subset of patients (e.g., iodine allergy, renal insufficiency), and reliance on non-contrast planning CT (pCT) alone may compromise soft-tissue contrast and introduce contouring uncertainty. We propose a Multi-Modal Generative Synthesis Network (MMGSN) to generate synthetic CECT (sCECT) from pCT and T2-weighted MRI, aiming to provide a non-invasive “virtual enhancement” tool for contouring support without physical contrast injection.

Materials/Methods:

We retrospectively collected 47 pelvic tumor patients treated with radiotherapy, each with paired non-contrast pCT, T2-weighted MRI, and ground-truth CECT. For each patient, the CECT volume used in this study consisted of 40 axial slices (used as the reference for training/evaluation). MMGSN adopts a dual-stream encoder to fuse the geometric fidelity of pCT with the soft-tissue characterization of MRI, followed by a decoder to reconstruct high-fidelity sCECT. Training employed a compound objective combining adversarial loss, weighted L1 loss, and SSIM loss. Performance was evaluated on a held-out test set using PSNR, SSIM, and MSE, and compared against the baseline similarity between pCT and CECT.

Results:

MMGSN generated sCECT with high quantitative fidelity to ground-truth CECT, achieving a mean PSNR of 43.36 dB and mean SSIM of 0.979 on the test set. Compared with the baseline (pCT vs CECT), MMGSN demonstrated a clear improvement in perceptual/structural similarity (e.g., representative case: SSIM 0.978 vs 0.966 and PSNR 43.088 vs 39.757, respectively). As illustrated in the tri-planar views (axial/coronal/sagittal), sCECT better reproduced contrast-related appearance and improved delineation cues for pelvic vasculature and soft-tissue boundaries relative to pCT, while maintaining geometric consistency required for radiotherapy planning.

Conclusion:

MMGSN enables high-quality generation of contrast-free sCECT from pCT and MRI in pelvic radiotherapy patients. This approach has the potential to provide clinically useful “virtual enhancement” for target/OAR contouring in patients with contrast contraindications, improving visualization without exposing patients to contrast-related risks and potentially streamlining radiotherapy workflows.